WSCM
IBB icon

Wellington Shields Capital Management’s iShares Biotechnology ETF IBB Stock Holding History

Wellington Shields Capital Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$696K Buy
3,660
+1,050
+40% +$180K 0.09% 141
2026
Q1 		$441K Buy
2,610
+690
+36% +$118K 0.07% 167
2025
Q4 		$324K Buy
+1,920
New +$312K 0.05% 197
2025
Q1 		– Sell
-39,663
Closed -$39.7K – 324
2024
Q4 		$39.7K Buy
39,663
+37,523
+1,753% +$5.28M 0.01% 286
2024
Q3 		$312K Hold
2,140
– – 0.05% 203
2024
Q2 		$294K Hold
2,140
– – 0.05% 199
2024
Q1 		$294K Buy
+2,140
New +$292K 0.06% 203
2023
Q1 		– Sell
-17,790
Closed -$2.34M – 328
2022
Q4 		$2.34M Hold
17,790
– – 0.28% 47
2022
Q3 		$2.08M Buy
17,790
+40
+0.2% +$4.97K 0.49% 50
2022
Q2 		$2.09M Sell
17,750
-20
-0.1% -$2.37K 0.26% 56
2022
Q1 		$2.31M Sell
17,770
-8,050
-31% -$1.05M 0.25% 64
2021
Q4 		$3.94M Sell
25,820
-2,601
-9% -$403K 0.5% 43
2021
Q3 		$4.59M Buy
28,421
+1
+0% +$168 0.63% 28
2021
Q2 		$4.65M Buy
28,420
+3,200
+13% +$493K 0.56% 35
2021
Q1 		$3.8M Sell
25,220
-1,450
-5% -$230K 0.36% 54
2020
Q4 		$4.04M Sell
26,670
-265
-1% -$37.9K 0.54% 37
2020
Q3 		$3.65M Sell
26,935
-1,275
-5% -$173K 0.58% 38
2020
Q2 		$3.86M Buy
+28,210
New +$3.6M 0.62% 34
2016
Q1 		– Sell
-2,505
Closed -$283K – 319
2015
Q4 		$283K Sell
2,505
-1,005
-29% -$109K 0.05% 259
2015
Q3 		$355K Buy
+3,510
New +$421K 0.06% 223

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Wellington Shields Capital Management's IBB Position: Q2 2026 in Review

Wellington Shields Capital Management increased its iShares Biotechnology ETF (IBB) stake by 40% in Q2 2026, buying an estimated $180K and bringing the position to 3,660 shares worth $696K. The position accounts for 0.09% of the portfolio, ranked #141.

Wellington Shields Capital Management first reported a position in IBB in Q3 2015 and has held it in 20 quarters since. The position peaked at $4.65M in Q2 2021. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Wellington Shields Capital Management held 3,660 shares of iShares Biotechnology ETF worth $696K as of Q2 2026.
  • Wellington Shields Capital Management bought 1,050 iShares Biotechnology ETF shares in Q2 2026, an estimated $180K.
  • iShares Biotechnology ETF made up 0.09% of Wellington Shields Capital Management's portfolio in Q2 2026, its #141 holding.
  • Wellington Shields Capital Management first reported a position in iShares Biotechnology ETF in Q3 2015 and has held it in 20 quarters since.
  • Wellington Shields Capital Management's iShares Biotechnology ETF position peaked at $4.65M in Q2 2021.
  • 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Wellington Shields Capital Management's 13F filing for Q2 2026, filed 10 Aug 2026.